There are no events in the calendar at the moment
A large number of research studies have been performed in all areas of application for Zenicor-EKG. These studies have established good diagnostic ability, in many cases clearly superior to conventional methods, and excellent results in terms of health economics. In addition to this, the research results have led to new, more efficient work methods for healthcare.
The research has developed an effective method to prevent stroke with primary preventive atrial fibrillation screening.
This method has attracted a great deal of attention globally, both within the research community and externally. It has also generated a new and effective care-pathway for patient presenting with symptoms of arrhythmias in primary care. The workflow digitalises the care pathway to make care more accessible for the patient, decreases pressure on specialist care which leads to a quicker diagnosis.
Research with Zenicor-EKG have been conducted at hospitals in Sweden, Denmark, Norway, Switzerland, Austria and the UK.